SCHEMBL23845320

SCHEMBL23845320

c1ccccc(NCC2CCCCCCCC2)cccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.57
CARM1 Q86X55 1/20 0.53
PRMT6 Q96LA8 1/20 0.53
EPHX2 P34913 1/20 0.51
APP P05067 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
ALDH1A1 P00352 2/20 0.44
MAPT P10636 1/20 0.44
ALOX12 P18054 1/20 0.44
HTT P42858 1/20 0.44
KCNH3 Q9ULD8 1/20 0.44
CRHR1 P34998 1/20 0.43
UTS2R Q9UKP6 2/20 0.43
ACHE P22303 1/20 0.43
BACE1 P56817 1/20 0.43
KDM4C Q9H3R0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL901572 1.00 EPHX1 (0.57) EPHX1CARM1PRMT6EPHX2APP
SCHEMBL22393075 1.00 EPHX1 (0.57) EPHX1CARM1PRMT6EPHX2APP
SCHEMBL901540 1.00 EPHX1 (0.57) EPHX1CARM1PRMT6EPHX2APP
SCHEMBL9679337 0.98 EPHX1 (0.54) EPHX1CARM1PRMT6EPHX2APP
SCHEMBL872221 0.94 CARM1 (0.54) EPHX1CARM1PRMT6EPHX2APP
Hydrogen Sulfide SCHEMBL15066150 0.92 CARM1 (0.53) EPHX1CARM1PRMT6EPHX2APP
Water SCHEMBL15066370 0.92 CARM1 (0.53) EPHX1CARM1PRMT6EPHX2APP
SCHEMBL10055002 0.89 CARM1 (0.57) EPHX1CARM1PRMT6MEN1KMT2A
SCHEMBL18434523 0.89 CARM1 (0.57) EPHX1CARM1PRMT6MEN1KMT2A
SCHEMBL10055063 0.89 CARM1 (0.57) EPHX1CARM1PRMT6MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021188696-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed